Upgrade

IGC Pharma, Inc.

IGC

Last
$0.28
Day
-2.8%
1y
-31.8%
5y
-80.5%
52w
-36.8%
SPY YTD
+13.3%
XLV
+8.1%
Earnings
2026-11-1334d
EMA 21
0.28
EMA 50
0.28
EMA 200
0.29
20d high
-4.4%
5y high
-84.1%
5y range
3th
Website · 70 employees · United States

Positions held

Your positions

IGC isn't in your positions.

Add it to see shares, cost, and P&L here.

Score
6
Hold
watch
Signal
Neutral
Target
$0.31
Stop
$0.27
Stop distance
2.5%
Target vs last
+11.9%

Fundamentals

Market cap$29.45MEnterprise value$30.18MTrailing P/E—Forward P/E-3.56
PEG—Price / book4.75Beta0.48Dividend yield0.00%
Revenue growth-19.2%Earnings growth—Gross margin46.2%Operating margin-10.5%
Profit margin0.0%ROE-83.3%ROA-50.3%Debt / equity0.18
Current ratio1.32Free cash flow-$2.52MAnalyst recommendationnoneMean target$6.00
52w high$0.4552w low$0.24

Quarterly

2026-Q22026-Q12025-Q42025-Q32025-Q22025-Q1
Revenue—$0.3M$0.3M$0.2M$0.3M$0.3M
Op margin—-775.4%-840.3%-1517.8%-580.8%-427.9%
Net income—-$2.4M-$0.7M-$1.8M-$1.6M-$1.2M
Gross margin—17.4%12.6%51.8%47.0%46.7%
Gross profit—$0.1M$0.0M$0.1M$0.2M$0.2M
Operating income—-$2.5M-$2.9M-$2.9M-$1.9M-$1.4M
  • Revenue -9% vs prior quarter ($0.3M vs $0.3M).
  • Gross margin 17.4% (was 12.6% prior quarter).
  • Operating margin expanded to -775.4%.

Yearly (6y)

2025202420232022
Revenue$1.3M$1.3M$0.9M$0.4M
Op margin-585.8%-728.5%-1270.1%-3886.1%
Net income-$7.1M-$13.0M-$11.5M-$15.0M
Gross margin48.7%54.5%48.5%48.9%
Gross profit$0.6M$0.7M$0.4M$0.2M
Operating income-$7.4M-$9.8M-$11.6M-$15.4M
Headline scan

No flags

• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).

News

IGC · daily+0.7% over 13 sessions
Close EMA21 EMA50 EMA200
0.260.270.280.290.302026-092026-092026-092026-092026-102026-102026-10
Quarterly · revenue, net income, margins
Revenue Net income Gross margin Op margin
-$2M-$2M-$1M-$0M$0M-1518%-733%52%2025-Q12025-Q22025-Q32025-Q42026-Q1